# FDA Inspection 1067927 - Biomat USA, Inc. - August 28, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ff44d57e-9acd-4dac-8473-93c40b5c08be/
Source feed: FDA_Inspections

> FDA Inspection 1067927 for Biomat USA, Inc. on August 28, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067927
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-08-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 947291 - 2015-08-21](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/34ded08b-9202-4431-bdfb-da4310d304e4/)
- [FDA Inspection 809389 - 2012-11-30](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/79e12e92-66d3-4cdf-b2d6-aef15af5a5f2/)
- [FDA Inspection 728552 - 2011-05-23](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/6383f45d-1b5d-4c3c-a738-9e8435a412cc/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/be87ad76-9675-4110-8e0f-97babef82f3e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d